Collaborative, Pharmacist-Led Approach Crucial in Polypharmacy
Emphasizing the pharmacist’s essential role, researchers explored the causes, consequences, and clinical implications of polypharmacy.
Meeting Preview: NPhA, SNPhA Annual Convention
This year’s conference is taking place from August 1 to 4 in Cincinnati, Ohio.
FDA Approves GSK’s Shingles Vaccine in Prefilled Syringe
The new presentation of Shingrix will allow for easier administration.
Q&A: Pharmacist's Voices Help Propel Industry Changes | McKesson ideaShare
Brooklyn Morgan, PharmD, discusses the transformation of pharmacy practice from a regulatory model to a more flexible approach.
Pharmacist-Led Interventions Show Promise in Improving COPD Outcomes
Researchers conducted a review of pharmacist interventions and their ability to impact the outcomes of patients with COPD.
Bristol Myers Squibb, Pfizer to Sell Eliquis Direct to Patients
The 2 corporations formed the Bristol Myers Squibb-Pfizer Alliance and will be offering discounted Eliquis to eligible patients starting September 8, 2025.
Q&A: Pharmacists Drive Better Insulin Outcomes Through Teamwork, Technology
Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM, discusses how pharmacists can collaborate with providers to optimize insulin therapy.
Q&A: Pharmacy Teams Leverage Technology and Collaboration to Optimize Inventory | McKesson ideaShare
Thomas Sherrer, PharmD, emphasizes teamwork and technology in inventory management to enhance patient safety and reduce medication errors.
Underserved Patients Less Resilient During Pandemic Than Affluent Communities
Researchers examined the factors attributed to self-reported resilience among diverse and community-dwelling adults during the COVID-19 pandemic.
Once Monthly Oral PrEP Medication Will Advance to Phase 3 Study
Investigators find that the phase 2 trial supports the further development of MK-8527 as an HIV pre-exposure prophylaxis.
Data Shows Amoxicillin Therapy Resistances for Invasive Pneumococcal Disease
New research reveals amoxicillin's effectiveness varies in treating invasive pneumococcal disease, highlighting the importance of patient-specific factors in antibiotic therapy.
COVID-19 Hospitalizations Disproportionately Impacted Black, Hispanic Children
Researchers characterized trends in COVID-19 hospitalizations by race and ethnicity among children from March 2020 to September 2023.
Pneumococcal Vaccination for Care Home Residents Prevents Cases, Deaths
Older adults are more likely to have chronic diseases, such as lung disease or heart disease, which makes them more susceptible to invasive pneumococcal disease.
Q&A: Pharmacies Optimize Inventory Management Through Teamwork | McKesson ideaShare
Thomas Sherrer, PharmD, advocates for a team-driven, tech-enhanced approach to pharmacy inventory management, boosting patient care and operational efficiency.
Tirzepatide, Hormone Therapy Combination Increases Weight Loss Among Postmenopausal Women
A recent study showed that 45% of women treated with both therapies achieved at least 20% total body weight loss.
Q&A: Pharmacists Play Essential Role in Insulin Therapy Success
Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM, discusses how pharmacists can help patients manage insulin.
Real-Time Prescription Benefit Tools Need to be Improved for Patients, Payers
Researchers addressed the current trends in prescription drug use and spending among Medicare Advantage beneficiaries during the first year of clinician access to a real-time prescription benefit tool.
CGRP Medication Did Not Prevent Cluster Headache Attacks
Investigators find that erenumab, a calcitonin gene-related peptide receptor (CGRP) monoclonal antibody, is not a preventative treatment for chronic cluster headache.
Delays in Hypertension Diagnosis Common, Associated with Adverse Outcomes
Researchers investigated the timing of hypertension diagnosis, exploring how it’s associated with medication prescribing and long-term cardiovascular outcomes.
Q&A: Congressman Highlights PBM Reform Bill | McKesson ideaShare
Congressman Buddy Carter (R-GA) champions the PBM Reform Act of 2025, aiming to enhance drug price transparency and empower pharmacists in healthcare delivery.
Q&A: How Advancements in GLP-1s, CGM Impact Insulin Management
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discusses how diabetes advancements like GLP-1s and CGM have impacted the management of insulin.
Improved Understanding of Hidradenitis Suppurativa Can Enhance Patient Outcomes
Researchers assessed the difference between hidradenitis suppurativa and other skin conditions regarding the initiating events, inflammatory signature, and molecular and clinical features of each disease.
Premenstrual Disorders Linked With Increased Cardiovascular Disease Risk
Investigators said they hope the findings contribute to greater awareness that premenstrual disorders can have long-term health consequences.
High Pneumococcal Disease Burden Persists Among Adults Over 65
Researchers conducted a retrospective cohort study to understand pneumococcal disease patterns, vaccine coverage, and the overall burden of the disease on adults in France.
Conference Recap: McKesson ideaShare Showcases Power of Independent Pharmacies
Pharmacists left the conference with fresh ideas, renewed confidence, and a strong sense that they're not in this alone.
FDA Approves Finerenone for Heart Failure With Left Ventricular Ejection Fraction
The approval is based on the FINEARTS-HF (NCT04435626), showing that the drug achieved a 16% relative risk reduction of cardiovascular death and total heart failure events.
Q&A: How IQVIA Keeps Pharmacists Engaged with US Prescription Drug Use
Michael Kleinrock from IQVIA joined Drug Topics to discuss his company’s recently released report, Understanding the Use of Medicines in the US 2025.
Insulin Advancements Led to Safer Surgeries, Shorter Hospital Stays
Researchers conducted a narrative review of the insulins available for diabetes management and which pharmacological options are best in the perioperative period and within clinical care.
Allergic-Related Skin Diseases Significantly Increased Since 1990
Researchers explored the global disease burden of allergic-related skin diseases from 1990 to 2021 and projected future disease trends.
Q&A: Current Advancements in Insulin Delivery for Patients with Diabetes
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, joins Drug Topics to discuss her extensive background in managing patients’ insulin regimens.
